DUBLIN–(BUSINESS WIRE)–The “Cell Culture Market by Product (Consumables (Media, FBS), Equipment (Bioreactor, Centrifuge, Incubator, Microscope, Autoclave)), Application (Stem Cell, Vaccines, Therapeutic proteins), End User – Global Forecast to 2024” report has been added to ResearchAndMarkets.com’s offering.
The cell culture market is expected to reach USD 29.17 billion by 2024 from USD 16.02 billion in 2019, at a CAGR of 12.7%.
This report provides a detailed picture of the global cell culture market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end-user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Increasing funding for cell-based research, growing benefits of the cell culture-based vaccines, and rising demand for monoclonal antibodies are expected to drive the overall growth of the cell culture market
This market is experiencing significant growth due to the growing awareness about the benefits of cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, growing focus on personalized medicine, and the launch of advanced cell culture products. On the other hand, the high cost of cell biology research and the lack of proper infrastructure for cell-based research activities are the major factors restraining the growth of this market.
Pharmaceutical and biotechnology companies are expected to dominate the market during the forecast period
Based on end-user, the cell culture market is segmented into research institutes, pharmaceutical & biotechnology companies, cell banks, and hospitals & diagnostic laboratories. In 2018, pharmaceutical and biotechnology companies accounted for the largest share of the cell culture market. The growing use of single-use technologies, increasing number of regulatory approvals for cell culture-based vaccines, and the presence of a large number of pharmaceutical players in this market are some of the factors driving the cell culture market for pharmaceutical and biotechnology companies.
Biopharmaceutical production to witness the highest growth in the cell culture market
Based on application, the cell culture market is categorized into biopharmaceutical production, stem cell research, diagnostics, drug discovery & development, tissue engineering & regenerative medicine, and other applications. The biopharmaceutical production segment is also expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the commercial expansion of major pharmaceutical companies, growing regulatory approvals for the production of cell culture-based vaccines, and increasing demand for monoclonal antibodies (mAbs).
North America to dominate the market during the forecast period
Geographically, the cell culture market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest share of the cell culture market. The growing regulatory approvals for cell culture-based vaccines, technological advancements, growth in the biotechnology and pharmaceutical industries, higher investments in cell-based research, rising incidence of diseases such as cancer, strong government support, and conferences and symposiums that create awareness on the latest trends in cell culture technology are the key factors driving the growth of the cell culture market in North America.
Market Dynamics
Drivers
- Growing Awareness About the Benefits of Cell Culture-Based Vaccines
- Increasing Demand for Monoclonal Antibodies
- Funding for Cell-Based Research
- Growing Preference for Single-Use Technologies
- Launch of Advanced Cell Culture Products
- Growing Focus on Personalized Medicine
Restraints
- High Cost of Cell Biology Research
- Lack of Infrastructure for Cell-Based Research in Emerging Economies
Opportunities
- Growing Demand for 3D Cell Culture
- Increased Risk of Pandemics and Communicable Diseases
- Emerging Economies
Key Topics Covered
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Currency
1.5 Limitation
1.6 Stakeholders
2 Research Methodology
2.1 Research Data
2.2 Secondary Data
2.3 Primary Data
2.4 Market Size Estimation
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Cell Culture: Market Overview
4.2 Asia Pacific: Cell Culture Market Share, By End User and Country (2019)
4.3 Cell Culture Sera, Media, & Reagents Market, By Type (USD Billion)
4.4 Cell Culture Market, By Application, 2019 vs 2024 (USD Billion)
4.5 Cell Culture Market, By Product, 2019 vs 2024 (USD Billion)
4.6 Geographical Snapshot of the Cell Culture Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
6 Cell Culture Market, By Product
6.1 Introduction
6.2 Consumables
6.3 Equipment
7 Cell Culture Market, By Application
7.1 Introduction
7.2 Biopharmaceutical Production
7.3 Diagnostics
7.4 Drug Screening and Development
7.5 Stem Cell Research
7.6 Tissue Engineering & Regenerative Medicine
7.7 Other Applications
8 Cell Culture Market, By End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.3 Hospitals and Diagnostic Laboratories
8.4 Research Institutes
8.5 Cell Banks
9 Cell Culture Market, By Region
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia Pacific
9.5 Rest of the World (RoW)
10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis, 2018
10.3 Competitive Scenario
10.4 Competitive Leadership Mapping (2019)
11 Company Profiles
- Becton, Dickinson and Company
- Cellgenix
- Corning
- Danaher
- Eppendorf
- Fujifilm Irvine Scientific (Acquired by Fujifilm Corporation)
- GE Healthcare (A Subsidiary of General Electric Company)
- Hi-Media Laboratories
- Invivogen
- Lonza Group AG
- Merck KGaA
- Miltenyi Biotec
- Promocell
- Sartorius AG
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/husl2i
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology